SEMAGLUTIDE 10mg

Semaglutide mimics the action of glucagon-like peptide-1 (GLP-1), a hormone released after food intake that binds to GLP-1 receptors in the pancreas, brain, and gastrointestinal tract. By activating these receptors, Semaglutide may enhance insulin secretion in a glucose-dependent manner, slow gastric emptying, and promote satiety through central appetite regulation. Its long half-life allows for sustained receptor activation, making it a key candidate in ongoing studies focused on obesity, diabetes, and metabolic syndrome.